Contract profitability requires real-time visibility into assets so manufacturers can make decisions proactively rather than reactively and maintain customer excellence.
Physicians need technology that helps them track disease progression and response to therapy.
Companies can improve their chances for a successful transition by leveraging their knowledge of their medical devices and understanding what each device’s categorization under the MDR means to its testing strategy.
Across our industry, IoMT will enable us to conduct research in ways that would never previously have been possible.
AdvaMed’s Diagnostic Supply Registry is tracking the progress of molecular diagnostic tests to help support state and federal governments.
While connected capabilities and wireless technology certainly lead to greater patient care, they also expose devices to greater cybersecurity risks.
As the proliferation of connected and complex medical devices grows, healthcare providers are more susceptible to cyberattacks.
Sources of reliable data to continuously support claims of compliance by manufacturers will be in high demand in the future.
Analysts expect 2020 to be a busy year for M&A activity.
All of the issues that ECRI calls out on its list are preventable, so device manufacturers and healthcare providers should take serious note.